/

/

Beckley Foundation

Small Pharma Reports Positive Top-line Data from SPL026 SSRI Drug Interaction Study

Beckley Foundation

Wed, Sep 27

Perspectives

DMT combined with SSRIs resulted in a 92% remission rate (compared to 20% in the DMT with no SSRIs group). But, sample size is quite small and VERY skewed: DMT + SSRI n = 12 DMT alone n = 5 Hope to see this replicate in larger, balanced cohorts. https://t.co/NkjG2JO52F

5597

Small Pharma's results suggest that SSRIs enhance the efficacy of SPL026 (DMT) when administered to Major Depressive Disorder patients.

Discover

Beckley Foundation